Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2007
06/07/2007WO2007063254A1 Composition in the form of a spray containing a corticoid and an oil phase
06/07/2007WO2007063087A1 Blackberry leaf extract as an active ingredient against skin irritations and inflammations
06/07/2007WO2007043702A9 Agent for applying to mucosa and method for production thereof
06/07/2007WO2007007115A3 Treatment of chronic ulcerous skin lesions
06/07/2007WO2006103354A3 Dermatological and/or cosmetic composition containing proteins of the sirt family
06/07/2007US20070130629 Renal Regulatory Elements and Methods of Use Thereof
06/07/2007US20070129430 Agent for enhancing the production of collagen, their preparation and use
06/07/2007US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
06/07/2007US20070129348 Receptor antagonist
06/07/2007US20070129325 Use of corrinoids for application in skin diseases
06/07/2007US20070129285 Protein a compositions and methods of use
06/07/2007US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases
06/07/2007US20070128616 Aggrecanase molecules
06/07/2007US20070128287 Dermal composition for external use
06/07/2007US20070128212 Ceramidase inhibitor
06/07/2007US20070128203 Anti-integrin antibodies, compositions, methods and uses
06/07/2007US20070128192 Human antibody molecules for il-13
06/07/2007US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
06/07/2007CA2631123A1 Composition in the form of a spray containing a corticoid and an oil phase
06/07/2007CA2629037A1 Compositions comprising a combination of ccr5 and cxcr4 antagonists
06/06/2007EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use
06/06/2007EP1792902A1 Processes for preparation of 5-(6-quinazolinyl)-furan-2-carbaldehydes
06/06/2007EP1792610A2 Sustained release bioadhesive therapeutic systems
06/06/2007EP1792608A2 Composition in the form of an oil-in-water emulsion and its cosmetic uses
06/06/2007EP1791598A1 Use of metronidazole combined with azelaic acid for the treatment of rosacea
06/06/2007EP1791552A2 Protein a compositions and methods of use
06/06/2007EP1684768A4 Methods of treating eczema
06/06/2007EP1496894A4 Angiogenesis inhibitors
06/06/2007EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
06/06/2007EP1406637B1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
06/06/2007EP1373270B1 Tricyclic quinoxaline derivatives as a uv filter
06/06/2007EP1363874B1 Tryptase inhibitors
06/06/2007EP1158958B1 Improved powdery pharmaceutical compositions for inhalation
06/06/2007DE102005057292A1 Formulation, useful e.g. for the caring of skin, nails and hair and for promoting hair growth and delay of the hair loss, comprises an active agent complex comprising germinated wheat flour, fenugreek seed extract and millet seed extract
06/06/2007CN1973896A Externally applied lotion for quick hair restoring
06/06/2007CN1973862A Externally applied hair restoring medicated wine
06/06/2007CN1973861A Hair blackening lotion
06/06/2007CN1973846A Medicine for treating burns and scalds
06/06/2007CN1319968C Compositions useful as inhibitors of GSK-3
06/06/2007CN1319959C Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors
06/06/2007CN1319957C Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
06/06/2007CN1319950C 3-substituted-4-pyrimidone derivatives
06/06/2007CN1319598C A composition for external use
06/06/2007CN1319597C Polysaccharide-containing compositions and use thereof
06/06/2007CN1319593C Oral enteric-coated microsphere of Thymosin and preparation thereof
06/06/2007CN1319562C Disinfectant bactericidal Chinese medicine preparation and producing process thereof
06/06/2007CN1319558C Medicine composition for treating skin itching and senile skin itching and its preparing method
06/06/2007CN1319554C Medicine composition with spot dispelling function and preparation thereof
06/06/2007CN1319543C Wild hibiscus Chinese medicine material and herbal pieces
06/06/2007CN1319540C Use of fucans in the treatment of adhesions, arthritis and psoriasis
06/06/2007CN1319536C Skin beautifying agent and food with heath caring and beautifying function
06/06/2007CN1319527C Use of tea polyphenol for preparing medicine for preventing and treating lipsotrichia induced from chemotherapy
06/06/2007CN1319516C Chinese medicine ointment and quality control thereof
06/05/2007USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2
06/05/2007US7227031 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents
06/05/2007US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
06/05/2007US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders
06/05/2007US7226972 Cosmetics, drugs
06/05/2007US7226943 Antilipemic agents
06/05/2007US7226937 Methods for modulating phototoxicity
06/05/2007US7226934 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen
06/05/2007US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use
06/05/2007US7226627 Grapeseed, cold-pressed grape oil, crushed grape and grape flour
06/05/2007US7226605 Botulinum toxin in the treatment or prevention of acne
06/05/2007CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion
06/05/2007CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
05/2007
05/31/2007WO2007061291A2 Method for in vivo multiplication of hair
05/31/2007WO2007061114A1 Pharmaceutical composition for prevention or treatment of neurogenic pain
05/31/2007WO2007061028A1 Gel composition for sterilization
05/31/2007WO2007060453A1 Promoting wound healing by administering a prostaglandin e and granulocyte-macrophage colony stimulating factor
05/31/2007WO2007060182A1 Use of n-(2-((3-(4-bromophenyl)-2-propenyl)amino)ethyl)-5-isoquinolinesulfonamide (h89) in a depigmenting pharmaceutical composition
05/31/2007WO2007059905A2 Thienopyrimidines treating inflammatory diseases
05/31/2007WO2007059584A1 Methods for wound healing
05/31/2007WO2007028524A3 Use of a derivative of imidazole for the treatment of leukotriene related disorders
05/31/2007WO2007022264A3 Oxides for wound healing and body repair
05/31/2007WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors
05/31/2007WO2006074370A3 Agonists and antagonists of tnfrii/cd120b for treatment of immune-related diseases
05/31/2007US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof
05/31/2007US20070123532 Piperazine derivatives
05/31/2007US20070123521 Cinnamoyl derivatives and use thereof
05/31/2007US20070123503 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
05/31/2007US20070123491 Podophyllotoxin derivatives as igf-1r inhibitors
05/31/2007US20070122464 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
05/31/2007US20070122454 Skin moisturizing agent for oral intake and functional foods and drinks
05/31/2007US20070122435 Topical dapsone for the treatment of acne
05/31/2007US20070122386 Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles
05/31/2007US20070122367 Resorcinol derivatives
05/31/2007US20070122354 possess superior aerosol properties, even in the absence of stabilizing carriers or excipients; inhalants; when administered to the deep lung, are useful for treating allergic diseases, such as asthma, atopy, and atopic dermatitis
05/31/2007DE102006054621A1 Pflanzliche Extrakte zur HAS-Stimulierung, insbesondere zur HAS2-Stimulierung Herbal extracts for HAS-stimulation, especially for HAS2 stimulation
05/31/2007DE102005057225A1 New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
05/31/2007DE102005057224A1 New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
05/31/2007CA2630818A1 Pharmaceutical composition for prevention or treatment of neurogenic pain
05/31/2007CA2629899A1 Methods for wound healing
05/30/2007EP1790728A2 Imaging, diagnosis and treatment of disease
05/30/2007EP1790655A2 Biologically active peptides
05/30/2007EP1790653A2 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
05/30/2007EP1790643A1 Quinuclidine compounds having quaternary ammonium group, it's preparation method and use as blocking agents of acetycholine
05/30/2007EP1790642A1 Biologically active methylene blue derivatives
05/30/2007EP1790640A1 Novel imidazolidine derivative and use thereof
05/30/2007EP1790354A2 Use of plasminogen for promoting healing of tympanic membrane perforation